News Daily News Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks Michael O'Riordan April 10, 2019
News Daily News Digital Tools Show Promise for Helping STEMI and NSTEMI Patients Avoid Readmission L.A. McKeown April 09, 2019
News Daily News Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD L.A. McKeown April 03, 2019
News Daily News Many Statin-Eligible Patients Don’t Take Meds, and Say Doctor Is to Blame Michael O'Riordan March 27, 2019
News Daily News FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients L.A. McKeown March 21, 2019
News Daily News ‘Striking’ Improvements in Acute MI Care Over Past 20 Years, Report Shows Michael O'Riordan March 19, 2019
News Daily News Bempedoic Acid Boosts LDL Cholesterol-Lowering in Statin-Treated CVD Patients: CLEAR Harmony Michael O'Riordan March 15, 2019
News Daily News High Rates of Unnecessary Aspirin Use in A-fib/VTE Patients on Warfarin Shelley Wood March 08, 2019
News Daily News Rising Inflammatory Tides: Increasing CRP Levels After ACS Tied to Greater CVD Risks Michael O'Riordan March 08, 2019
News Daily News FDA Provides Update on Tainted ARB Investigation, With New Impurity Found Todd Neale March 04, 2019
News Daily News ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD Michael O'Riordan March 01, 2019
News Daily News Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics Caitlin E. Cox February 27, 2019
News Daily News New Equations Help ID Patients at Low Risk for Bleeding With Aspirin Michael O'Riordan February 26, 2019
News Daily News DOACs Maintain Advantage Over Warfarin in A-fib Patients With Low Body Weight Todd Neale February 25, 2019
News Daily News FDA Adds Boxed Warning About CV Risks to Gout Drug Febuxostat Shelley Wood February 22, 2019
News Daily News Lower Statin Adherence Linked to Higher Mortality Risk, Even Among Patients With Established ASCVD Lucy Hicks February 15, 2019
News Daily News Alirocumab Price Cut Makes Second PCSK9 Inhibitor More Affordable Shelley Wood February 12, 2019